1. Platelets containing adenine nucleotides labelled with3H and14C in vitro were aggregated biphasically with ADP and adrenaline. Amounts of ATP and ADP as well as the radioactivity of ATP, ADP, AMP, IMP, hypoxanthine and adenine were determined in platelets and plasma at different stages of aggregation. 2. ATP and ADP were released during the second aggregation phase and had a low specific radioactivity compared with the ATP and ADP retained by the cells. The specific radioactivity of intracellular nucleotides increased during release. The parameters observed with ADP and adrenaline as release inducers were the same as for collagen and thrombin. 3. Release induced by all four inducers was accompanied by conversion of cellular [3H]ATP into extracellular [3H]-hypoxanthine. By variation of temperature, inducer concentration, time after blood withdrawal and use of acetylsalicylic acid, the aggregation pattern caused by adrenaline and ADP could be made mono- or bi-phasic. Release or second-phase aggregation was intimately connected with the ATP–hypoxanthine conversion, whereas first phase aggregation was not. 4. The [3H]ATP–hypoxanthine conversion started immediately after ADP addition. With adrenaline it usually started with the appearance of the second aggregation phase. The conversion was present during first phase of ADP-induced aggregation only if a second phase were to follow. 5. When secondary aggregation took place while radioactive adenine was being taken up by the platelets, increased formation of labelled hypoxanthine still occurred, but there was either no change or an increase in the concentration of labelled ATP. 6. Biphasically aggregated platelets converted [3H]adenine more rapidly into [3H]-ATP and -hypoxanthine than non-aggregated platelets. Addition of [3H]adenine at different stages of biphasic aggregation showed that more [3H]hypoxanthine was formed during than after the release step. 7. We conclude that ADP and adrenaline, like thrombin and collagen, cause extrusion of non-metabolic granula-located platelet adenine nucleotides. During release metabolic ATP breaks down to hypoxanthine, and this process might reflect an ATP-requiring part of the release reaction.
Skip Nav Destination
Article navigation
August 1972
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Research Article|
August 01 1972
Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline
Holm Holmsen
;
Holm Holmsen
1Thrombosis Research Center, Temple University Health Science Center, Philadelphia, Pa., U.S.A., and Institute for Thrombosis Research, Rikshospitalet, Oslo, Norway
Search for other works by this author on:
H. James Day
;
H. James Day
1Thrombosis Research Center, Temple University Health Science Center, Philadelphia, Pa., U.S.A., and Institute for Thrombosis Research, Rikshospitalet, Oslo, Norway
Search for other works by this author on:
Carol A. Setkowsky
Carol A. Setkowsky
1Thrombosis Research Center, Temple University Health Science Center, Philadelphia, Pa., U.S.A., and Institute for Thrombosis Research, Rikshospitalet, Oslo, Norway
Search for other works by this author on:
Biochem J (1972) 129 (1): 67–82.
Citation
Holm Holmsen, H. James Day, Carol A. Setkowsky; Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline. Biochem J 1 August 1972; 129 (1): 67–82. doi: https://doi.org/10.1042/bj1290067
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Related Articles
Metabolism of hypoxanthine in isolated rat hepatocytes
Biochem J (August,1984)
The bactericidal/permeability-increasing protein (BPI) in the innate defence of the lower airways
Biochem Soc Trans (July,2011)
Hypoxanthine enters human vascular endothelial cells (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter
Biochem J (August,1996)
Metabolism of xanthine and hypoxanthine in the tea plant ( Thea sinensis L.)
Biochem J (January,1975)